Negative impact of neoadjuvant hormonal therapy on detecting biochemical recurrence after radical prostatectomy-Reference-Cited by-同舟云学术

Negative impact of neoadjuvant hormonal therapy on detecting biochemical recurrence after radical prostatectomy

Published:2021-06-04 Issue:9 Volume:26 Page:1722-1728
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Matsumoto Kazuhiro^ORCID,Niwa Naoya,Kosaka Takeo,Takeda Toshikazu,Yasumizu Yota,Tanaka Nobuyuki,Morita Shinya,Mizuno Ryuichi,Shinojima Toshiaki,Asanuma Hiroshi,Oya Mototsugu

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-021-01942-8.pdf

Reference29 articles.

1. Hamdy FC, Donovan JL, Lane JA et al (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375(15):1415–1424

2. Kakehi Y, Sugimoto M, Taoka R, Committee for establishment of the evidenced-based clinical practice guideline for prostate cancer of the Japanese Urological Association (2017) evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urological Association, 2016 edition). Int J Urol 24(9):648–666

3. Matsumoto K, Niwa N, Hagiwara M et al (2020) Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy. World J Urol 38(7):1749–1756

4. Pfister D, Bolla M, Briganti A et al (2014) Early salvage radiotherapy following radical prostatectomy. Eur Urol 65(6):1034–1043

5. Matsumoto K, Mizuno R, Tanaka N et al (2014) Optimal timing of hormonal therapy for prostate-specific antigen recurrence after radical prostatectomy. Med Oncol 31(7):45